With the analysis among 8,997 patents, we discovered top 485 key players by total patent application. Celgene Corp., BASF AB, Syngenta Ltd. are dominant in this area. They take 7.40% of the total patent filing.
New Jersey, United States
Patent: 272
BERKSHIRE, United Kingdom
Patent: 148
California, United States
Patent: 116
Nordrhein-Westfalen, Germany
Patent: 115
Basel-Stadt, Switzerland
Patent: 112
Syngenta Participations AG
F. Hoffmann-La Roche Ltd.
Imperial Chemical Industries Ltd.
With the analysis among 138 patents, we discovered top 17 start-ups by total patent application. Biosplice Therapeutics, Inc., Metriopharm AG, Actuate Therapeutics, Inc. are active in this area.
Biosplice Therapeutics, Inc.
California, United States
Patent: 45
ZURICH, Switzerland
Patent: 44
Actuate Therapeutics, Inc.
Texas, United States
Patent: 15
Basel-Stadt, Switzerland
Patent: 8
Cass Pharmaceuticals, Inc.
Tennessee, United States
Patent: 8
Institut National de la Santé et de la Recherche Médicale
California, United States
Patent: 3
New Jersey, United States
Patent: 2
Sumitomo Dainippon Pharma Oncology, Inc.
General Biosystems (Anhui) Corp. Ltd.
Anhui Sheng, China
Patent: 1
With the analysis among related 2,177 patents applied in the last 5 years. We discover 500 most active companies in this area. The fast-growing Celgene Corp., Novartis AG, Capital University of Medical Sciences take 11.07% of patent filing during this period.
New Jersey, United States
Patent: 129
Basel-Stadt, Switzerland
Patent: 77
Capital University of Medical Sciences
Beijing Shi, China
Patent: 35
California, United States
Patent: 34
Zhejiang University of Technology
Zhejiang Sheng, China
Patent: 26
ZURICH, Switzerland
Patent: 25
Shin-Etsu Chemical Co., Ltd.
Tokyo-to, Japan
Patent: 22
Indiana, United States
Patent: 22
Dow Global Technologies LLC
Michigan, United States
Patent: 19
Ampio Pharmaceuticals, Inc.
Colorado, United States
Patent: 18
With the analysis among related 2,177 patents in last 5 years, we discover 309 new entrants. Actuate Therapeutics, Inc., Aquafortus Technologies Ltd., Hunan Kerey Pharmaceutical Co., Ltd. are the most active new entrants in this area.
Actuate Therapeutics, Inc.
Texas, United States
Patent: 15
Aquafortus Technologies Ltd.
Auckland, New Zealand
Patent: 11
Hunan Kerey Pharmaceutical Co., Ltd.
Hunan Sheng, China
Patent: 10
Nordrhein-Westfalen, Germany
Patent: 10
Beijing Houshen Weikang Technology Co., Ltd.
Beijing Shi, China
Patent: 9
Basel-Stadt, Switzerland
Patent: 8
Cass Pharmaceuticals, Inc.
Tennessee, United States
Patent: 8
Beijing Green Man Technology Co., Ltd.
Beijing Shi, China
Patent: 7
With the analysis among 1,611 patents, we discovered top 309 universities and scientific research institutions by total patent application. Capital University of Medical Sciences, Zhejiang University of Technology, Sichuan Normal University are dominant in this area. They take 8.81% of the total patent filing.
Capital University of Medical Sciences
Beijing Shi, China
Patent: 65
Zhejiang University of Technology
Zhejiang Sheng, China
Patent: 42
Sichuan Normal University
Sichuan Sheng, China
Patent: 35
Shanghai Shi, China
Patent: 19
Zhejiang Sheng, China
Patent: 19
Henan Sheng, China
Patent: 19
The Johns Hopkins University
South China University of Technology
Guangdong Sheng, China
Patent: 17
East China University of Science & Technology
Shanghai Shi, China
Patent: 15
Council of Scientific & Industrial Research